Using pharmacy data on partial adherence to inform clinical care of patients with serious mental illness

Psychiatric Services

Volumn 58, Issue 6, 2007, Pages 864-867

  Woltmann, Emily M ^a,b   Valenstein, Marcia ^c,d   Welsh, Deborah E ^c   Lee, Todd A ^e,f   Wolschon, Patricia A ^g   Grabowski, John ^g   Reilly, Peter A ^g  

^a DARTMOUTH PSYCHIATRIC RESEARCH CENTER   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e HINES VA HOSPITAL   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ACCURACY; ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CONFIDENCE INTERVAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; PATIENT CARE; PHARMACY; PRESCRIPTION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCREENING; VETERAN;

EID: 34250885177     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.2007.58.6.864     Document Type: Article

References (15)

1. Lehman AF, Kreyenbuhl J, Buchanan BW, et al: The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. Schizophrenia Bulletin 30:193-217, 2004
2. American Psychiatric Association: Practice Guideline for the Treatment of Patients With Bipolar Disorder. Arlington, Va, American Psychiatric Association, 2002
3. Viguera AC, Baldessarini RJ, Hegarty JD, et al: Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Archives of General Psychiatry 54:49-55, 1997
4. Lacro JP, Dunn LB, Dolder CR, et al: Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 63: 892-909, 2002
5. Valenstein M, Barry KL, Blow FC, et al: Agreement between seriously mentally ill veterans and their clinicians about medication compliance. Psychiatric Services 49:1043-1048, 1998
6. Weiden PJ, Kozma C, Grogg A, et al: Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services 55:886-891, 2004
7. Eaddy M, Grogg A, Locklear J: Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population. Clinical Therapeutics 27:263-272, 2005
8. Svarstad BL, Shireman TI, Sweeney JK: Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatric Services 52:805-811, 2001
9. Gilmer TP, Dolder CR, Lacro JP, et al: Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry 161:692-699, 2004
10. Valenstein M, Copeland LA, Blow FC, et al: Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care 40:630-639, 2002
11. Szeto HC, Coleman RK, Gholami P, et al: Accuracy of computerized outpatient diagnoses in a Veterans Affairs general medicine clinic. American Journal of Managed Care 8:37-43, 2002
12. Lurie N, Popkin M, Dysken M, et al: Accuracy of diagnoses of schizophrenia in Medicaid claims. Hospital and Community Psychiatry 43:69-71, 1992
13. Desai RA, Rosenheck RA, Rothbard A: Cross-system service use among VA mental health patients living in Philadelphia. Admissions Policy and Mental Health 28:299-309, 2001
14. Osterberg L, Blaschke T: Adherence to medication. New England Journal of Medicine 353:487-497, 2005
15. Agha Z, Lofgren RP, VanRuiswyk JV, et al: Are patients at Veterans Affairs Medical Centers sicker? A comparative analysis of health status and medical resource use. Archives of Internal Medicine 160:3252-3257, 2000